David Gerald Greenspan serves as Executive at Cyclerion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Gerald Greenspan has executed 1 insider transactions totaling $3.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 3, 2021 involved purchasing 961,538 shares valued at $3.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 3, 2021 | CYCN | $3.0M | Purchase | 961,538 | $3.12 | Discretionary |
David Gerald Greenspan currently holds 7,157,601 shares of Cyclerion Therapeutics, Inc. (CYCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Gerald Greenspan has been a net buyer of CYCN stock. They have purchased $3.0M and sold $0 worth of shares.
David Gerald Greenspan's most recent insider trade was on Jun 3, 2021, when they purchased 961,538 shares at $3.12 per share.
Get notified when new Form 4 filings are submitted